全文获取类型
收费全文 | 457篇 |
免费 | 20篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 7篇 |
基础医学 | 43篇 |
口腔科学 | 1篇 |
临床医学 | 79篇 |
内科学 | 138篇 |
神经病学 | 15篇 |
特种医学 | 17篇 |
外科学 | 101篇 |
综合类 | 7篇 |
预防医学 | 25篇 |
眼科学 | 1篇 |
药学 | 16篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 1篇 |
2023年 | 5篇 |
2022年 | 10篇 |
2021年 | 23篇 |
2020年 | 6篇 |
2019年 | 20篇 |
2018年 | 18篇 |
2017年 | 16篇 |
2016年 | 13篇 |
2015年 | 10篇 |
2014年 | 29篇 |
2013年 | 23篇 |
2012年 | 32篇 |
2011年 | 24篇 |
2010年 | 11篇 |
2009年 | 17篇 |
2008年 | 24篇 |
2007年 | 23篇 |
2006年 | 33篇 |
2005年 | 35篇 |
2004年 | 42篇 |
2003年 | 16篇 |
2002年 | 29篇 |
2001年 | 7篇 |
2000年 | 4篇 |
1999年 | 2篇 |
1985年 | 2篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有478条查询结果,搜索用时 15 毫秒
381.
Revision strategies for lumbar pseudarthrosis 总被引:3,自引:0,他引:3
Revision surgery for pseudarthrosis remains costly and complicated. Local and systemic factors should be corrected or improved before further surgery is performed. Careful evaluation is mandatory, and patients' expectations should be addressed fully by the surgeon before undertaking any surgical procedure. The single most important factor in achieving a successful clinical outcome in revision spine surgery is patient selection. Pseudarthrosis is still one of the most difficult conditions to assess as a source of symptoms, and not surprisingly the outcome from repair of pseudarthrosis is the most difficult to predict. In evaluation of a solid fusion, the preliminary test includes plain radiographs that include flexion and extension films. More definitive evaluation of pseudarthrosis usually requires CT with two-dimensional and possibly three-dimensional reconstruction. Adjacent levels and the status of neural structures may be evaluated via MRI scanning, discography, and myelography. After determining the presence of pseudarthrosis and ascertaining through clinical examination and evaluation the level of symptomatic pseudarthrosis, operative intervention may be considered once conservative management has failed. Posterior procedures for revision of a failed lumbar fusion have not yielded reliably successful results; however, this approach does have a significant role in the appropriately selected candidate. A combined anteroposterior approach may be more effective in restoring sagittal balance and enhancing fusion rates. The use of posterior instrumentation in light of an anterior pseudarthrosis or anterior support in light of a posterior pseudarthrosis is a viable option for treatment in these circumstances. Several osteoinductive growth factors, referred to as bone morphogenetic proteins, have been shown to induce transformation of undifferentiated mesenchymal cells into chondroblasts and osteoblasts, which results in the formation of de novo bone. Numerous animal studies have demonstrated the superiority of bone morphogenetic proteins over autogenous bone grafts in various orthopedic settings. Bone morphogenetic protein (by itself or in conjunction with autogenous bone) has been shown repeatedly to produce a better quality of spine fusion in a decreased interval of time when compared with the use of autogenous bone alone. These materials, however, remain investigational and currently are not widely used. Prevention of pseudarthrosis is the most successful treatment, although this is not always possible. Appropriate patient selection, surgical techniques, and the use of biologic implants and gene therapy in the near future will make spinal fusion a more predictable procedure to perform. Undoubtedly there is great difficulty in performing satisfactory and statistically verifiable conclusions from the available published studies. Better prospective outcomes studies are needed to improve our knowledge regarding overall patient satisfaction, function, residual pain, and health impact of the treatment of lumbar spine pseudarthrosis. 相似文献
382.
This study investigated the association between effectiveness of ED pain treatment and race of patients, race of providers, and the concordance of patient and provider race, with a prospective, multicenter study of patients presenting to 1 of 20 US and Canadian EDs with moderate to severe pain. Primary outcome is a 2-point or greater reduction in pain intensity, measured with an 11-point verbal scale, considered the minimum clinically important reduction in pain intensity. A total of 776 patients were enrolled. The sample included 57% female, 44% white, 26% black, and 26% Hispanic. The physician was white in 85% of encounters. Arrival pain score (adjusted odds ratio, 1.14; 95% CI 1.06, 1.24), receipt of any ED analgesia (1.59; 95% CI 1.17, 2.17), and physician nonwhite race (1.68; 95% CI 1.10, 2.55) were significant predictors of clinically significant reduction in pain intensity in multivariate analysis. Nonwhite physicians achieved better pain control without using more analgesics. Future research should explore the determinants of this difference in patient response to pain treatment related to provider race including provider characteristics and training that were not measured in this study. This study provided no evidence supporting an effect of racial concordance on the primary outcome.PerspectiveThis article presents analysis of predictors of clinically important reduction in pain intensity among emergency department patients, finding nonwhite physicians achieving better pain relief with less analgesia. This finding should encourage researchers to investigate elements of the therapeutic relationship that may be enhanced to achieve better pain relief for patients. 相似文献
383.
Min Lou Adnan Safdar Jonathan A. Edlow Louis Caplan Sandeep Kumar Gottfried Schlaug D. Eric Searls Richard P. Goddeau Magdy Selim 《International journal of emergency medicine》2010,3(2):75-80
Background
The ABCD2 score is increasingly being used to triage patients with transient ischemic attack (TIA). Whether the score can predict the need for in-hospital intervention (IHI), other than initiation of antiplatelets and statins, is unknown.Aims
The ability of the ABCD2 score to predict IHI would strengthen the rationale to use it as a decision-making tool. We thus conducted this study to investigate the relationship between the ABCD2 score and IHI.Methods
We analyzed prospectively collected data from consecutive TIA patients over 12 months. We determined ABCD2 upon admission and collected the results of in-hospital evaluation, treatments initiated during hospitalization, and follow-up status. We defined IHI as arterial revascularization or anticoagulation required during admission. We used chi-square for trend to examine the association between ABCD2 and IHI.Results
We studied 121 patients. Fourteen (12%) had small infarcts on diffusion magnetic resonance imaging; 38 (31%) had a new risk factor recognized during admission [hyperlipidemia (n?=?9), hypertension (1), diabetes (1), carotid stenosis ≥ 50% (16), other arterial occlusive lesions (7), and potential cardioembolic source (4)]. Their percentages increased with higher ABCD2 scores. However, among 12 patients (10%) with IHI, ABCD2 score categories were equally distributed (10% in 0–3, 9% in 4–5, and 10% in 6–7; p?=?0.8). One patient (0.8%) worsened during hospitalization; none had a stroke during follow-up.Conclusion
Patients with an ABCD2 score ≤ 3 had an equal chance of requiring IHI as those with a score of 4–7. The decision to admit TIA patients based on the ABCD2 score alone is not supported by our experience and requires further study. 相似文献384.
Gastric rupture secondary to bulimia is a rare complication of anorexia nervosa first described in 1968. We present a case of an 18-year-old woman who presented to the Emergency Department with acute gastric rupture leading to both tension pneumoperitoneum and tension pneumothorax. Although case reports of spontaneous pneumoperitoneum and separate reports of spontaneous pneumothorax in anorexic patients have been published, none of them has been associated with gastric rupture. 相似文献
385.
Purpose The recovery of gastrointestinal function following surgery for congenital intestinal atresias can be prolonged and may increase
morbidity and hospital stay. This study was conducted to investigate the prokinetic effect of erythromycin in neonates undergoing
surgery for small bowel atresias.
Methods A randomized-controlled trial was conducted at the Departments of Paediatrics and Paediatric Surgery, Military Hospital, Rawalpindi,
Pakistan, from January to December 2007 to study the prokinetic effect of erythromycin (3 mg/kg per dose 4 times daily). Thirty
consecutive neonates undergoing primary anastomosis for congenital small bowel atresias were randomly divided into two groups:
group I (erythromycin) and group II (control). The groups were similar in terms of gestational age, sex, mode of delivery,
birth weight and types of atresias. Postoperative recovery of intestinal functions was measured as time taken to achieve full
enteral feed (150 ml/kg per 24 h), duration of total parenteral nutrition (TPN) and hospital stay.
Results Neonates receiving oral erythromycin achieved full enteral feeding early (13.07 vs. 16.13 days) required TPN for shorter duration
(10.53 vs. 13.73 days) and their hospital stay was less (16.2 vs. 18.0 days) as compared to the neonates in the control group
who did not receive any erythromycin. The differences were statistically significant.
Conclusion The administration of oral erythromycin following primary anastomosis for small intestinal atresias results in early recovery
of intestinal function, fewer days on TPN and a trend for shorter hospital stay. 相似文献
386.
Safdar Z 《Respiratory medicine》2011,105(6):818-827
Pulmonary arterial hypertension is a progressive, fatal disease characterized by elevated pulmonary arterial pressure ≥25 mm Hg and normal pulmonary capillary wedge pressure ≤ 5 mm Hg. Physiological features of pulmonary arterial hypertension are characterized clinically by the presence of pre-capillary pulmonary hypertension not caused by other conditions such as lung diseases or chronic thromboembolic pulmonary hypertension. There are several therapies currently available that have been shown to improve hemodynamics and improve outcomes in patients with pulmonary arterial hypertension. These therapies include synthetic prostacyclin and prostaglandin analogs, endothelin receptor antagonists, and phosphodiesterase-5 inhibitors. Multiple prostacyclin and prostaglandin analog formulations are currently in use (both branded and generic), available for parenteral, inhaled, or oral administration. This review discusses the pharmacology, clinical effects, and routes of administration of prostacyclin and prostaglandin analogs, emphasizing the advantages and disadvantages of each from the clinical perspective. 相似文献
387.
388.
389.
390.